Literature DB >> 21067512

Nitric oxide and disorders of the erythrocyte: emerging roles and therapeutic targets.

Jason H Maley1, George F Lasker, Philip J Kadowitz.   

Abstract

Nitric oxide (NO) plays an important role in states of erythrocyte dysfunction, including sickle cell disease (SCD), malaria, and banked blood preservation. By understanding the role of nitric oxide in these conditions, which are accompanied by hemolysis, vasoocclusion, and erythrocyte dysfunction, new therapeutic targets may be identified to treat complications of these disease states. Furthermore, the role of the erythrocyte in the controlled release of NO in hypoxic tissues is of particular interest, and two theories are discussed regarding this mechanism. In this article, the role of nitric oxide in erythrocyte function, sickle cell anemia, malaria, and damage to banked blood is reviewed, and the use of NO targeted therapies for erythrocyte disease states is discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21067512     DOI: 10.2174/187152910793743878

Source DB:  PubMed          Journal:  Cardiovasc Hematol Disord Drug Targets        ISSN: 1871-529X


  4 in total

Review 1.  Updated role of nitric oxide in disorders of erythrocyte function.

Authors:  Marc J Kahn; Jason H Maley; George F Lasker; Philip J Kadowitz
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2013-03-01

2.  Design, Synthesis, and Antisickling Investigation of a Nitric Oxide-Releasing Prodrug of 5HMF for the Treatment of Sickle Cell Disease.

Authors:  Rana T Alhashimi; Mohini S Ghatge; Akua K Donkor; Tanvi M Deshpande; Nancy Anabaraonye; Dina Alramadhani; Richmond Danso-Danquah; Boshi Huang; Yan Zhang; Faik N Musayev; Osheiza Abdulmalik; Martin K Safo
Journal:  Biomolecules       Date:  2022-05-12

3.  L-arginine/NO pathway is altered in children with haemolytic-uraemic syndrome (HUS).

Authors:  Nele Kirsten Kanzelmeyer; Lars Pape; Kristine Chobanyan-Jürgens; Dimitrios Tsikas; Hans Hartmann; Anne-Jule Fuchs; Bernhard Vaske; Anibh Martin Das; Marion Haubitz; Jens Jordan; Thomas Lücke
Journal:  Oxid Med Cell Longev       Date:  2014-03-17       Impact factor: 6.543

Review 4.  Therapeutic approaches to limit hemolysis-driven endothelial dysfunction: scavenging free heme to preserve vasculature homeostasis.

Authors:  Francesca Vinchi; Emanuela Tolosano
Journal:  Oxid Med Cell Longev       Date:  2013-05-27       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.